WW de Herder

1.1k total citations
13 papers, 844 citations indexed

About

WW de Herder is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, WW de Herder has authored 13 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in WW de Herder's work include Neuroendocrine Tumor Research Advances (7 papers), Pituitary Gland Disorders and Treatments (5 papers) and Neuroblastoma Research and Treatments (4 papers). WW de Herder is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Pituitary Gland Disorders and Treatments (5 papers) and Neuroblastoma Research and Treatments (4 papers). WW de Herder collaborates with scholars based in Netherlands, Germany and United States. WW de Herder's co-authors include AJ van der Lely, Larry K. Kvols, Bertram Wiedenmann, Eugene A. Woltering, Philippe Ruszniewski, Guido Rindi, G. Delle Fave, Martyn Caplin, K. Öberg and J. A. M. J. L. Janssen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

WW de Herder

13 papers receiving 819 citations

Peers

WW de Herder

EPIDE

NEURO

ONCOL

EDM

SURGE

Maria Vittoria Davì Italy

Catherine Bauters France

Simon Schimmack Germany

Aude Houchard France

Seraina Muletta-Feurer Switzerland

J.C. Reubi Netherlands

Eleftherios Chatzellis Greece

M Schlumberger France

Erika Grossrubatscher Italy

R Bonacci Italy

Maria Vittoria Davì Italy

WW de Herder

370 ×0.7

EPIDE

250 ×0.6

NEURO

287 ×0.7

ONCOL

385 ×1.1

EDM

173 ×1.2

SURGE

Citations per year, relative to WW de Herder WW de Herder (= 1×) peers Maria Vittoria Davì

Countries citing papers authored by WW de Herder

Since Specialization

Citations

This map shows the geographic impact of WW de Herder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WW de Herder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WW de Herder more than expected).

Fields of papers citing papers by WW de Herder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WW de Herder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WW de Herder. The network helps show where WW de Herder may publish in the future.

Co-authorship network of co-authors of WW de Herder

This figure shows the co-authorship network connecting the top 25 collaborators of WW de Herder. A scholar is included among the top collaborators of WW de Herder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WW de Herder. WW de Herder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wyld, David, Tessa Brabander, Jaap J.M. Teunissen, et al.. (2018). A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine. Neuroendocrinology. 106. 261–261. 3 indexed citations

Plantinga, Theo S., Peer Arts, L.A.B. Joosten, et al.. (2017). Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Clinical Pharmacology & Therapeutics. 102(6). 1017–1024. 10 indexed citations

Kvols, Larry K., Bertram Wiedenmann, Kjell Öberg, et al.. (2010). Efficacy, Safety and Pharmacokinetic Results from a Phase II Study of Pasireotide (SOM230) in the Treatment of Patients with Metastatic NETs Refractory or Resistant to Octreotide LAR. Neuroendocrinology. 92(1). 42–43. 5 indexed citations

Versleijen‐Jonkers, Yvonne M.H., Sandra M.H. Claessen, Aurel Perren, et al.. (2007). DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine Related Cancer. 14(3). 769–779. 32 indexed citations

Kvols, Larry K., J. E. Glusman, Elizabeth A. Hahn, et al.. (2007). The effects of pasireotide (SOM230) on health-related quality of life in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR. Journal of Clinical Oncology. 25(18_suppl). 4558–4558. 10 indexed citations

Kvols, Larry K., Bertram Wiedenmann, Kjell Öberg, et al.. (2006). Safety and efficacy of pasireotide (SOM230) in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR: Results of a phase II study. Journal of Clinical Oncology. 24(18_suppl). 4082–4082. 48 indexed citations

Feenstra, J, et al.. (2005). Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. The Lancet. 365(9471). 1644–1646. 179 indexed citations

Kvols, Larry K., Kjell Öberg, WW de Herder, et al.. (2005). Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR. Journal of Clinical Oncology. 23(16_suppl). 8024–8024. 11 indexed citations

Öberg, K., Larry K. Kvols, Martyn Caplin, et al.. (2004). Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Annals of Oncology. 15(6). 966–973. 415 indexed citations

10.

Hofland, Leo J., Joost van der Hoek, P. M. van Koetsveld, et al.. (2003). The novel somatostatin analog SOM230 has a broad spectrum of inhibitory action on hormone release by human somatotroph, corticotroph and PRL-secreting pituitary adenomas in vitro. Open Repository and Bibliography (University of Liège). 2 indexed citations

11.

Koning, Eelco J.P. de, et al.. (2002). Sequential ACTH and catecholamine secretion in a phaeochromocytoma. European Journal of Endocrinology. 147(2). 201–206. 20 indexed citations

12.

Janssen, J. A. M. J. L., et al.. (2002). Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly. European Journal of Endocrinology. 147(2). 195–199. 12 indexed citations

13.

Herder, WW de, et al.. (1998). Pituitary insufficiency. The Lancet. 352(9122). 127–134. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact